Clinical TrialID 4840

Effectiveness of Theobromine Toothpaste

NCT05187507

Dental Plaque|Dental Care

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
4840
Evidence Id
4840
Core Evidence Id
4840
Source Clinical Trial Id
4815
Herb2 Clinical Trial Id
HBCT004815
Nct Id
NCT05187507
Title
Effectiveness of Theobromine Toothpaste
Status
Completed
Phase
Study Result
No
Study Condition
Dental Plaque|Dental Care
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Intervention
OTHER: Evaluation of the effectiveness of low- fluoridated toothpaste.|OTHER: Evaluation of the effectiveness of fluoridated toothpaste.|OTHER: Evaluation of the effectiveness of theobromine toothpaste (2%) toothpaste.|OTHER: Evaluation of the effectiveness of theobromine toothpaste(4%) toothpaste.
Intervention Allocation
Randomized
Intervention Model
Parallel
Intervention Mask
Triple
Intervention Purpose
Prevention
Gender
All
Age
Child
Enrollment
80
Outcome Measure
Clinical evaluation of using low- fluoridaed toothpaste for children, Plaque scores will be assess by using the Turesky Modification of the Quigley-Hein Plaque Index(TMQHPI) for both buccal and lingual surfaces. Plaque will detect using plaque disclosing agent. Gingival scores will be assessed with gingival index(loe and silness)., 1 week|Clinical evaluation of using low- fluoridaed toothpaste for children, Plaque scores will be assess by using the Turesky Modification of the Quigley-Hein Plaque Index(TMQHPI) for both buccal and lingual surfaces. Plaque will detect using plaque disclosing agent. Gingival scores will be assessed with gingival index(loe and silness)., 2 week|Clinical evaluation of using low- fluoridaed toothpaste for children, Plaque scores will be assess by using the Turesky Modification of the Quigley-Hein Plaque Index(TMQHPI) for both buccal and lingual surfaces. Plaque will detect using plaque disclosing agent. Gingival scores will be assessed with gingival index(loe and silness)., 3 week|Clinical evaluation of using fluoridated toothpaste for children, Plaque scores will be assess by using the Turesky Modification of the Quigley-Hein Plaque Index(TMQHPI) for both buccal and lingual surfaces. Plaque will detect using plaque disclosing agent. Gingival scores will be assessed with gingival index(loe and silness)., 1 week|Clinical evaluation of using fluoridated toothpaste for children, Plaque scores will be assess by using the Turesky Modification of the Quigley-Hein Plaque Index(TMQHPI) for both buccal and lingual surfaces. Plaque will detect using plaque disclosing agent. Gingival scores will be assessed with gingival index(loe and silness)., 2 week|Clinical evaluation of using fluoridated toothpaste for children, Plaque scores will be assess by using the Turesky Modification of the Quigley-Hein Plaque Index(TMQHPI) for both buccal and lingual surfaces. Plaque will detect using plaque disclosing agent. Gingival scores will be assessed with gingival index(loe and silness)., 3 week|Clinical evaluation of using theobromine toothpaste(2%) for children, Plaque scores will be assess by using the Turesky Modification of the Quigley-Hein Plaque Index(TMQHPI) for both buccal and lingual surfaces. Plaque will detect using plaque disclosing agent. Gingival scores will be assessed with gingival index(loe and silness)., 1 week|Clinical evaluation of using theobromine toothpaste(2%) for children, Plaque scores will be assess by using the Turesky Modification of the Quigley-Hein Plaque Index(TMQHPI) for both buccal and lingual surfaces. Plaque will detect using plaque disclosing agent. Gingival scores will be assessed with gingival index(loe and silness)., 2 week|Clinical evaluation of using theobromine toothpaste(2%) for children, Plaque scores will be assess by using the Turesky Modification of the Quigley-Hein Plaque Index(TMQHPI) for both buccal and lingual surfaces. Plaque will detect using plaque disclosing agent. Gingival scores will be assessed with gingival index(loe and silness)., 3 week|Clinical evaluation of using theobromine toothpaste(4%) for children, Plaque scores will be assess by using the Turesky Modification of the Quigley-Hein Plaque Index(TMQHPI) for both buccal and lingual surfaces. Plaque will detect using plaque disclosing agent. Gingival scores will be assessed with gingival index(loe and silness)., 1 week|Clinical evaluation of using theobromine toothpaste(4%) for children, Plaque scores will be assess by using the Turesky Modification of the Quigley-Hein Plaque Index(TMQHPI) for both buccal and lingual surfaces. Plaque will detect using plaque disclosing agent. Gingival scores will be assessed with gingival index(loe and silness)., 2 week|Clinical evaluation of using theobromine toothpaste(4%) for children, Plaque scores will be assess by using the Turesky Modification of the Quigley-Hein Plaque Index(TMQHPI) for both buccal and lingual surfaces. Plaque will detect using plaque disclosing agent. Gingival scores will be assessed with gingival index(loe and silness)., 3 week
Sponsor Collaborator
Damascus University
Funded By
OTHER
Location
Damascus University, Damascus, 30621, Syrian Arab Republic
Other Id
UDDS-Pedo-06-2021
Start Date
2021-09-25
Primary Completion Date
2021-11-01
Completion Date
2021-12-01
First Posted
2022-01-11
Results First Posted
Last Update Posted
2022-01-11
Study Document
Study Url
https://clinicaltrials.gov/study/NCT05187507
Title Cn
Title En
Effectiveness of Theobromine Toothpaste
Bilingual Status
semi_complete